648 related articles for article (PubMed ID: 11283375)
1. Continuous fatty acid oxidation and reduced fat storage in mice lacking acetyl-CoA carboxylase 2.
Abu-Elheiga L; Matzuk MM; Abo-Hashema KA; Wakil SJ
Science; 2001 Mar; 291(5513):2613-6. PubMed ID: 11283375
[TBL] [Abstract][Full Text] [Related]
2. LKB1 and the regulation of malonyl-CoA and fatty acid oxidation in muscle.
Thomson DM; Brown JD; Fillmore N; Condon BM; Kim HJ; Barrow JR; Winder WW
Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1572-9. PubMed ID: 17925454
[TBL] [Abstract][Full Text] [Related]
3. Decreased muscle acetyl-coenzyme A carboxylase 2 mRNA and insulin resistance in formerly obese subjects.
Rosa G; Manco M; Vega N; Greco AV; Castagneto M; Vidal H; Mingrone G
Obes Res; 2003 Nov; 11(11):1306-12. PubMed ID: 14627750
[TBL] [Abstract][Full Text] [Related]
4. Increased malonyl-CoA levels in muscle from obese and type 2 diabetic subjects lead to decreased fatty acid oxidation and increased lipogenesis; thiazolidinedione treatment reverses these defects.
Bandyopadhyay GK; Yu JG; Ofrecio J; Olefsky JM
Diabetes; 2006 Aug; 55(8):2277-85. PubMed ID: 16873691
[TBL] [Abstract][Full Text] [Related]
5. Glucose and fat metabolism in adipose tissue of acetyl-CoA carboxylase 2 knockout mice.
Oh W; Abu-Elheiga L; Kordari P; Gu Z; Shaikenov T; Chirala SS; Wakil SJ
Proc Natl Acad Sci U S A; 2005 Feb; 102(5):1384-9. PubMed ID: 15677334
[TBL] [Abstract][Full Text] [Related]
6. Hepatic de novo lipogenesis is present in liver-specific ACC1-deficient mice.
Harada N; Oda Z; Hara Y; Fujinami K; Okawa M; Ohbuchi K; Yonemoto M; Ikeda Y; Ohwaki K; Aragane K; Tamai Y; Kusunoki J
Mol Cell Biol; 2007 Mar; 27(5):1881-8. PubMed ID: 17210641
[TBL] [Abstract][Full Text] [Related]
7. Mutant mice lacking acetyl-CoA carboxylase 1 are embryonically lethal.
Abu-Elheiga L; Matzuk MM; Kordari P; Oh W; Shaikenov T; Gu Z; Wakil SJ
Proc Natl Acad Sci U S A; 2005 Aug; 102(34):12011-6. PubMed ID: 16103361
[TBL] [Abstract][Full Text] [Related]
8. Malonyl-CoA and carnitine in regulation of fat oxidation in human skeletal muscle during exercise.
Roepstorff C; Halberg N; Hillig T; Saha AK; Ruderman NB; Wojtaszewski JF; Richter EA; Kiens B
Am J Physiol Endocrinol Metab; 2005 Jan; 288(1):E133-42. PubMed ID: 15383373
[TBL] [Abstract][Full Text] [Related]
9. Expression of genes regulating malonyl-CoA in human skeletal muscle.
Pender C; Trentadue AR; Pories WJ; Dohm GL; Houmard JA; Youngren JF
J Cell Biochem; 2006 Oct; 99(3):860-7. PubMed ID: 16721829
[TBL] [Abstract][Full Text] [Related]
10. Malonyl CoA control of fatty acid oxidation in the newborn heart in response to increased fatty acid supply.
Onay-Besikci A; Sambandam N
Can J Physiol Pharmacol; 2006 Nov; 84(11):1215-22. PubMed ID: 17218986
[TBL] [Abstract][Full Text] [Related]
11. Regulation of food intake and energy expenditure by hypothalamic malonyl-CoA.
Lane MD; Wolfgang M; Cha SH; Dai Y
Int J Obes (Lond); 2008 Sep; 32 Suppl 4():S49-54. PubMed ID: 18719599
[TBL] [Abstract][Full Text] [Related]
12. Liver-specific deletion of acetyl-CoA carboxylase 1 reduces hepatic triglyceride accumulation without affecting glucose homeostasis.
Mao J; DeMayo FJ; Li H; Abu-Elheiga L; Gu Z; Shaikenov TE; Kordari P; Chirala SS; Heird WC; Wakil SJ
Proc Natl Acad Sci U S A; 2006 May; 103(22):8552-7. PubMed ID: 16717184
[TBL] [Abstract][Full Text] [Related]
13. AMPK-independent pathways regulate skeletal muscle fatty acid oxidation.
Dzamko N; Schertzer JD; Ryall JG; Steel R; Macaulay SL; Wee S; Chen ZP; Michell BJ; Oakhill JS; Watt MJ; Jørgensen SB; Lynch GS; Kemp BE; Steinberg GR
J Physiol; 2008 Dec; 586(23):5819-31. PubMed ID: 18845612
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of acetyl-CoA carboxylase 2 enhances skeletal muscle fatty acid oxidation and improves whole-body glucose homeostasis in db/db mice.
Glund S; Schoelch C; Thomas L; Niessen HG; Stiller D; Roth GJ; Neubauer H
Diabetologia; 2012 Jul; 55(7):2044-53. PubMed ID: 22532389
[TBL] [Abstract][Full Text] [Related]
15. Muscle type-specific fatty acid metabolism in insulin resistance: an integrated in vivo study in Zucker diabetic fatty rats.
Beha A; Juretschke HP; Kuhlmann J; Neumann-Haefelin C; Belz U; Gerl M; Kramer W; Roden M; Herling AW
Am J Physiol Endocrinol Metab; 2006 May; 290(5):E989-97. PubMed ID: 16380389
[TBL] [Abstract][Full Text] [Related]
16. A null mutation in skeletal muscle FAT/CD36 reveals its essential role in insulin- and AICAR-stimulated fatty acid metabolism.
Bonen A; Han XX; Habets DD; Febbraio M; Glatz JF; Luiken JJ
Am J Physiol Endocrinol Metab; 2007 Jun; 292(6):E1740-9. PubMed ID: 17264223
[TBL] [Abstract][Full Text] [Related]
17. Down-regulation in muscle and liver lipogenic genes: EPA ethyl ester treatment in lean and overweight (high-fat-fed) rats.
Pérez-Echarri N; Pérez-Matute P; Marcos-Gómez B; Marti A; Martínez JA; Moreno-Aliaga MJ
J Nutr Biochem; 2009 Sep; 20(9):705-14. PubMed ID: 18829285
[TBL] [Abstract][Full Text] [Related]
18. Malonyl-CoA content and fatty acid oxidation in rat muscle and liver in vivo.
Chien D; Dean D; Saha AK; Flatt JP; Ruderman NB
Am J Physiol Endocrinol Metab; 2000 Aug; 279(2):E259-65. PubMed ID: 10913024
[TBL] [Abstract][Full Text] [Related]
19. AMPK and ACC phosphorylation: effect of leptin, muscle fibre type and obesity.
Janovská A; Hatzinikolas G; Staikopoulos V; McInerney J; Mano M; Wittert GA
Mol Cell Endocrinol; 2008 Mar; 284(1-2):1-10. PubMed ID: 18255222
[TBL] [Abstract][Full Text] [Related]
20. Minimal impact of age and housing temperature on the metabolic phenotype of Acc2-/- mice.
Brandon AE; Stuart E; Leslie SJ; Hoehn KL; James DE; Kraegen EW; Turner N; Cooney GJ
J Endocrinol; 2016 Mar; 228(3):127-34. PubMed ID: 26668208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
